Novartis Institutes Business Development Manager Salaries in Providence, RI
The average Novartis Institutes Business Development Manager in Providence, RI earns an estimated $154,951 annually, which includes an estimated base salary of $116,985 with a $37,966 bonus. Novartis Institutes' Business Development Manager compensation is $22,810 more than the US average for a Business Development Manager. Business Development Manager salaries at Novartis Institutes in Providence, RI can range from $48,888 - $300,000.
In Providence, RI, The Business Development Department at Novartis Institutes earns $334 more on average than the IT Department.
Last updated 2 years ago.
- $116,985
- avg. base
- $37,966
- avg. bonus
Business Development Manager Salaries at Novartis Institutes
In Providence, RI, Business Development Managers earn $5,968 more than Business Development Managers.
Compensation at Novartis Institutes by Department
In Providence, RI, The Business Development Department averages $334 more than the IT Department, and $2,441 less than the Sales Department
Business Development Manager Compensation by Gender (All Companies)
The average female Business Development Manager at companies similar size to Novartis Institutes reported making $145,609, while the average male Business Development Manager at similar sized companies reported making $146,331.
Business Development Manager Compensation by Ethnicity (All Companies)
The average Asian or Pacific Islander Business Development Manager at companies similar size to Novartis Institutes reported making $164,200, while the average Native American Business Development Manager at similar sized companies reported making $48,888.
How Business Development Managers at Novartis Institutes Rate Their Compensation
The majority of Business Development Managers at Novartis Institutes believe they're compensated fairly. 100% of Business Development Managers at Novartis Institutes say they receive annual bonuses, and the vast majority (100%) are satisfied with their benefits. See more compensation ratings at Novartis Institutes
